Biotron CEO to Review Portfolio and Define Sedrx Strategy
Biotron says its CEO will review the portfolio, define the Sedrx strategy and evaluate asset pathways.
Biotron says its CEO will review the portfolio, define the Sedrx strategy and evaluate asset pathways.